MPM BioImpact LLC Diversified Active

CIK: 0001687078 · Show all filings

Period: Q1 2024 (← Previous) (Next →)

Filing Date: May 15, 2024

Total Value ($000): $621,981 (100.0% shares, 0.0% debt)

Holdings (38)

CGEM Cullinan Oncology, Inc. 21.0%

Value ($000) $130,326 Shares 7,648,268 Est. Cost $40.60 Unrealized -61.9%

GERN Geron Corporation 5.6%

Value ($000) $34,570 Shares 10,475,675 Est. Cost $1.65 Unrealized +35.5%

IOVA Iovance Biotherapeutics Inc 5.2%

Value ($000) $32,604 Shares 2,200,000 Est. Cost $9.98 Unrealized +16.6%

ZNTL Zentalis Pharmaceuticals, Inc. 3.8%

Value ($000) $23,895 Shares 1,516,183 Est. Cost $13.75 Unrealized 0.0%

— iTeos Therapeutics, Inc. 3.8%

Value ($000) $23,815 Shares 1,745,943 Est. Cost $24.67 Unrealized —

— Sutro Biopharma, Inc. 3.7%

Value ($000) $23,146 Shares 4,096,619 Est. Cost $5.65 Unrealized —

CRNX Crinetics Pharmaceuticals Inc. 3.6%

Value ($000) $22,496 Shares 480,588 Est. Cost $21.22 Unrealized +84.4%

OLMA Olema Pharmaceuticals, Inc. 3.6%

Value ($000) $22,116 Shares 1,953,690 Est. Cost $9.34 Unrealized +38.1%

MDGL Madrigal Pharmaceuticals inc 2.6%

Value ($000) $16,396 Shares 61,399 Est. Cost $169.34 Unrealized +39.1%

NTRA Natera Inc 2.5%

Value ($000) $15,769 Shares 172,413 Est. Cost $75.21 Unrealized 0.0%

HOWL Werewolf Therapeutics, Inc. 2.5%

Value ($000) $15,474 Shares 2,388,011 Est. Cost $13.70 Unrealized -57.5%

MLTX Moonlake Immunotherapeutics 2.4%

Value ($000) $14,871 Shares 296,050 Est. Cost $26.91 Unrealized +101.6%

— Avadel Pharmaceuticals PLC 2.4%

Value ($000) $14,714 Shares 871,149 Est. Cost $14.59 Unrealized —

INSM Insmed Incorporated 2.3%

Value ($000) $14,400 Shares 530,794 Est. Cost $19.24 Unrealized +45.4%

ALXO ALX Oncology Holdings Inc. 2.3%

Value ($000) $14,143 Shares 1,268,471 Est. Cost $9.49 Unrealized +48.0%

VKTX VIKING THERAPEUTICS INC 2.0%

Value ($000) $12,300 Shares 150,000 Est. Cost $14.30 Unrealized +211.1%

NTLA Intellia Therapeutics, Inc. 1.9%

Value ($000) $11,901 Shares 432,598 Est. Cost $71.71 Unrealized -61.3%

RGNX REGENXBIO Inc. 1.9%

Value ($000) $11,569 Shares 549,078 Est. Cost $29.05 Unrealized -38.7%

RARE Ultragenyx Pharmaceutical Inc 1.8%

Value ($000) $11,467 Shares 245,590 Est. Cost $47.17 Unrealized 0.0%

— MORPHIC HOLDING INC 1.8%

Value ($000) $11,452 Shares 325,333 Est. Cost $25.19 Unrealized —

— 89Bio Inc 1.8%

Value ($000) $11,265 Shares 967,742 Est. Cost $11.64 Unrealized —

VRDN Viridian Therapeutics Inc 1.7%

Value ($000) $10,751 Shares 614,010 Est. Cost $20.41 Unrealized -5.0%

FULC Fulcrum Therapeutics Inc 1.7%

Value ($000) $10,734 Shares 1,137,108 Est. Cost $8.93 Unrealized 0.0%

XERS Xeris Biopharma Holdings Inc 1.5%

Value ($000) $9,208 Shares 4,166,496 Est. Cost $2.55 Unrealized +1.5%

AXSM Axsome Therapeutics, Inc. 1.5%

Value ($000) $9,107 Shares 114,127 Est. Cost $67.96 Unrealized +23.5%

KALV Kalvista Pharmaceuticals Inc 1.5%

Value ($000) $9,022 Shares 760,722 Est. Cost $13.33 Unrealized 0.0%

RVMD Revolution Medicines, Inc. 1.4%

Value ($000) $8,806 Shares 273,217 Est. Cost $26.97 Unrealized +9.9%

— Verve Therapeutics, Inc 1.4%

Value ($000) $8,475 Shares 638,163 Est. Cost $30.36 Unrealized —

FOLD Amicus Therapeutics Inc. 1.4%

Value ($000) $8,469 Shares 718,970 Est. Cost $11.28 Unrealized +13.4%

— Akero Therapeutics Inc 1.4%

Value ($000) $8,410 Shares 332,924 Est. Cost $25.26 Unrealized —

ADAPY Adaptimmune Therapeutics plc 1.3%

Value ($000) $8,052 Shares 5,095,912 Est. Cost $0.93 Unrealized —

EWTX Edgewise Therapeutics Inc 1.3%

Value ($000) $8,049 Shares 441,259 Est. Cost $15.89 Unrealized 0.0%

— Repare Therapeutics, Inc. 1.2%

Value ($000) $7,724 Shares 1,639,849 Est. Cost $31.02 Unrealized —

RLAY Relay Therapeutics Inc. 1.1%

Value ($000) $6,906 Shares 832,017 Est. Cost $17.41 Unrealized -44.0%

IRON Disc Medicine Inc 1.1%

Value ($000) $6,897 Shares 110,779 Est. Cost $58.68 Unrealized +10.5%

TRVI Trevi Therapeutics Inc 0.7%

Value ($000) $4,626 Shares 1,340,960 Est. Cost $2.23 Unrealized 0.0%

— Immatics NV 0.7%

Value ($000) $4,154 Shares 395,237 Est. Cost $10.51 Unrealized —

CMPX Compass Therapeutics, Inc. 0.6%

Value ($000) $3,903 Shares 1,971,402 Est. Cost $1.73 Unrealized 0.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
CGEM	Cullinan Oncology, Inc.	7,648,268	$130,326	21.0%	$40.60	-61.9%	Common	230031106
GERN	Geron Corporation	10,475,675	$34,570	5.6%	$1.65	+35.5%	Common	374163103
IOVA	Iovance Biotherapeutics Inc	2,200,000	$32,604	5.2%	$9.98	+16.6%	Common	462260100
ZNTL	Zentalis Pharmaceuticals, Inc.	1,516,183	$23,895	3.8%	$13.75	0.0%	Common	98943L107
—	iTeos Therapeutics, Inc.	1,745,943	$23,815	3.8%	$24.67	—	Common	46565G104
—	Sutro Biopharma, Inc.	4,096,619	$23,146	3.7%	$5.65	—	Common	869367102
CRNX	Crinetics Pharmaceuticals Inc.	480,588	$22,496	3.6%	$21.22	+84.4%	Common	22663K107
OLMA	Olema Pharmaceuticals, Inc.	1,953,690	$22,116	3.6%	$9.34	+38.1%	Common	68062P106
MDGL	Madrigal Pharmaceuticals inc	61,399	$16,396	2.6%	$169.34	+39.1%	Common	558868105
NTRA	Natera Inc	172,413	$15,769	2.5%	$75.21	0.0%	Common	632307104
HOWL	Werewolf Therapeutics, Inc.	2,388,011	$15,474	2.5%	$13.70	-57.5%	Common	95075A107
MLTX	Moonlake Immunotherapeutics	296,050	$14,871	2.4%	$26.91	+101.6%	Class A Ord	61559X104
—	Avadel Pharmaceuticals PLC	871,149	$14,714	2.4%	$14.59	—	Sponsored ADR	05337M104
INSM	Insmed Incorporated	530,794	$14,400	2.3%	$19.24	+45.4%	Common	457669307
ALXO	ALX Oncology Holdings Inc.	1,268,471	$14,143	2.3%	$9.49	+48.0%	Common	00166B105
VKTX	VIKING THERAPEUTICS INC	150,000	$12,300	2.0%	$14.30	+211.1%	Common	92686J106
NTLA	Intellia Therapeutics, Inc.	432,598	$11,901	1.9%	$71.71	-61.3%	Common	45826J105
RGNX	REGENXBIO Inc.	549,078	$11,569	1.9%	$29.05	-38.7%	Common	75901B107
RARE	Ultragenyx Pharmaceutical Inc	245,590	$11,467	1.8%	$47.17	0.0%	Common	90400D108
—	MORPHIC HOLDING INC	325,333	$11,452	1.8%	$25.19	—	Common	61775R105
—	89Bio Inc	967,742	$11,265	1.8%	$11.64	—	Common	282559103
VRDN	Viridian Therapeutics Inc	614,010	$10,751	1.7%	$20.41	-5.0%	Common	92790C104
FULC	Fulcrum Therapeutics Inc	1,137,108	$10,734	1.7%	$8.93	0.0%	Common	359616109
XERS	Xeris Biopharma Holdings Inc	4,166,496	$9,208	1.5%	$2.55	+1.5%	Common	98422E103
AXSM	Axsome Therapeutics, Inc.	114,127	$9,107	1.5%	$67.96	+23.5%	Common	05464T104
KALV	Kalvista Pharmaceuticals Inc	760,722	$9,022	1.5%	$13.33	0.0%	Common	483497103
RVMD	Revolution Medicines, Inc.	273,217	$8,806	1.4%	$26.97	+9.9%	Common	76155X100
—	Verve Therapeutics, Inc	638,163	$8,475	1.4%	$30.36	—	Common	92539P101
FOLD	Amicus Therapeutics Inc.	718,970	$8,469	1.4%	$11.28	+13.4%	Common	03152W109
—	Akero Therapeutics Inc	332,924	$8,410	1.4%	$25.26	—	Common	00973Y108
ADAPY	Adaptimmune Therapeutics plc	5,095,912	$8,052	1.3%	$0.93	—	Sponsored ADR	00653A107
EWTX	Edgewise Therapeutics Inc	441,259	$8,049	1.3%	$15.89	0.0%	Common	28036F105
—	Repare Therapeutics, Inc.	1,639,849	$7,724	1.2%	$31.02	—	Common	760273102
RLAY	Relay Therapeutics Inc.	832,017	$6,906	1.1%	$17.41	-44.0%	Common	75943R102
IRON	Disc Medicine Inc	110,779	$6,897	1.1%	$58.68	+10.5%	Common	254604101
TRVI	Trevi Therapeutics Inc	1,340,960	$4,626	0.7%	$2.23	0.0%	Common	89532M101
—	Immatics NV	395,237	$4,154	0.7%	$10.51	—	Common	N44445909
CMPX	Compass Therapeutics, Inc.	1,971,402	$3,903	0.6%	$1.73	0.0%	Common	20454B104